Results
2
Companies with a Value score of at least 3, ordered by Value score
2 companies
argenx
Market Cap: €34.8b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€568.40
7D
-3.3%
1Y
16.4%
UCB
Market Cap: €35.1b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€184.50
7D
-0.08%
1Y
19.9%